Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells - PubMed (original) (raw)
Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells
H E Broxmeyer et al. J Exp Med. 1989.
Abstract
Two recently identified and purified murine macrophage inflammatory proteins MIP-1 and MIP-2 were tested in vitro both alone, and in combination with purified recombinant (r) murine (mu) GM-CSF, natural (n)muCSF-1, or rhuman (hu)G-CSF, for effects on mouse marrow CFU-GM, in combination with erythropoietin for effects on mouse marrow BFU-E, and in combination with rhuGM-CSF or rhuG-CSF for effects on human marrow CFU-GM. MIP-1 and MIP-2 did not stimulate, but did enhance by up to threefold, colony formation of mouse CFU-GM co-stimulated by rmuGM-CSF and nmuCSF-1, but not by rhuG-CSF, in the absence or presence of serum. MIP-1 and MIP-2 were maximally active at concentrations greater than or equal to 100 ng/ml and the actions appeared to be initiated during the DNA synthetic portion of the cell cycle. Neither MIP-1 nor MIP-2 at up to 1 microgram/ml had any effect on mouse BFU-E, in the absence or presence of erythropoietin. Both MIP-1 and MIP-2 had direct acting effects on purified mouse CFU-GM. The cloning efficiency of 200 purified cells plated with 50 U muCSF-1 was 82% with and 43% without MIP; the cloning efficiency with 50 U rmuGM-CSF was 65% with and 35% without MIP. MIP effects were not mimicked by bacterial LPS, rhuIL-1 alpha, rhuIL-6, or rmuIL-4, and were neutralized by their respective specific antibodies. MIP-1 and MIP-2 also enhanced endogenously stimulated and rhuGM-CSF-, but not rhuG-CSF-, stimulated colony formation by human marrow CFU-GM. These results demonstrate a new role for MIP-1 and MIP-2 in vitro as myelopoietic enhancing activities for CFU-GM.
Similar articles
- Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells.
Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh KO, Tekamp-Olson P, Kwon BS, Cerami A. Broxmeyer HE, et al. Blood. 1990 Sep 15;76(6):1110-6. Blood. 1990. PMID: 2205307 - Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
Broxmeyer HE, Cooper S, Lu L, Hangoc G, Anderson D, Cosman D, Lyman SD, Williams DE. Broxmeyer HE, et al. Blood. 1991 May 15;77(10):2142-9. Blood. 1991. PMID: 1709371 - GM-CSF and G-CSF in hematology and oncology.
Offner FC, Van Hove WZ. Offner FC, et al. Acta Clin Belg. 1989;44(5):318-25. doi: 10.1080/17843286.1989.11718034. Acta Clin Belg. 1989. PMID: 2481926 Review. - The role of haemopoietic growth factors in bone marrow transplantation.
Goldstone AH, Khwaja A. Goldstone AH, et al. Leuk Res. 1990;14(8):721-9. doi: 10.1016/0145-2126(90)90102-f. Leuk Res. 1990. PMID: 1697007 Review.
Cited by
- Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy.
Rodriguez J, Iniguez A, Jena N, Tata P, Liu ZY, Lander AD, Lowengrub J, Van Etten RA. Rodriguez J, et al. Elife. 2023 Apr 28;12:e84149. doi: 10.7554/eLife.84149. Elife. 2023. PMID: 37115622 Free PMC article. - Neutrophil-Dependent Immunity During Pulmonary Infections and Inflammations.
Effah CY, Drokow EK, Agboyibor C, Ding L, He S, Liu S, Akorli SY, Nuamah E, Sun T, Zhou X, Liu H, Xu Z, Feng F, Wu Y, Zhang X. Effah CY, et al. Front Immunol. 2021 Oct 19;12:689866. doi: 10.3389/fimmu.2021.689866. eCollection 2021. Front Immunol. 2021. PMID: 34737734 Free PMC article. Review. - The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.
Staversky RJ, Byun DK, Georger MA, Zaffuto BJ, Goodman A, Becker MW, Calvi LM, Frisch BJ. Staversky RJ, et al. Sci Rep. 2018 Oct 2;8(1):14691. doi: 10.1038/s41598-018-32978-y. Sci Rep. 2018. PMID: 30279500 Free PMC article. - Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3.
Schaller TH, Batich KA, Suryadevara CM, Desai R, Sampson JH. Schaller TH, et al. Expert Rev Clin Immunol. 2017 Nov;13(11):1049-1060. doi: 10.1080/1744666X.2017.1384313. Epub 2017 Oct 5. Expert Rev Clin Immunol. 2017. PMID: 28965431 Free PMC article. Review. - Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
Mukaida N, Tanabe Y, Baba T. Mukaida N, et al. Int J Mol Sci. 2017 Aug 22;18(8):1824. doi: 10.3390/ijms18081824. Int J Mol Sci. 2017. PMID: 28829353 Free PMC article. Review.
References
- Exp Hematol. 1977 Mar;5(2):87-102 - PubMed
- FASEB J. 1989 Jun;3(8):1956-62 - PubMed
- Proc Natl Acad Sci U S A. 1983 Jul;80(13):4114-8 - PubMed
- Cancer Res. 1986 Sep;46(9):4357-61 - PubMed
- Exp Hematol. 1987 Mar;15(3):243-50 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials